W
WAVEMAN · COMPANY
IMAX · Imax Corp
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475
← ALL COMPANIES

IMAX

IMAX CORP
MEDICAL DEVICES · PHOTOGRAPHIC EQUIPMENT & SUPPLIES · CIK 0000921582
FORM 144 · 8☆ WATCH
INSIDER NET · 180D
-$63.1M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
138
13F, latest reported quarter
REVENUE GROWTH
+16.5%
XBRL, annual
NET MARGIN
8.5%
CONVERSIONS · 180D
20
codes C/M, not in net · $26.6M priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$63.1M over 180 days
-$28.0M over 90 days · -$16.5M of it by a 10%+ holder
below 96% of Medical Devices
CONGRESS
no member of Congress has reported trading it
FUNDS
138 funds added or opened last quarter
more than 65% of Medical Devices
REVENUE
+16.5% year over year
more than 70% of Medical Devices
MARGIN
8.5% net margin
more than 74% of Medical Devices
BUYBACKS
no share repurchases reported
SHORT
14.2% of shares outstanding short · 3.8 days to cover · settled 2026-07-31
more than 94% of Medical Devices
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$63.1M across 7 people in 180 days.
138 funds added or opened positions in the latest 13F quarter, of 260 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +76.4%
+76.4%12M
-0%+29%+58%+87%2025-092025-102025-122026-032026-052026-072026-09 2026-03-16 · DOUGLAS KEVIN sold $12.5M2026-08-19 · GELFOND RICHARD L sold $10.9M2026-08-18 · GELFOND RICHARD L sold $7.7M2026-08-20 · GELFOND RICHARD L sold $5.3M2026-04-10 · GELFOND RICHARD L sold $5.1M2026-03-10 · GELFOND RICHARD L sold $4.9M2026-04-13 · GELFOND RICHARD L sold $3.6M2026-03-16 · DOUGLAS KEVIN sold $2.4M2025-11-10 · WELTON MARK sold $1.7M2025-11-07 · LISTER ROBERT D sold $1.7M2026-03-16 · DOUGLAS KEVIN sold $1.7M2026-08-25 · WELTON MARK sold $1.6M2026-04-16 · GELFOND RICHARD L sold $1.5M2026-04-17 · GELFOND RICHARD L sold $1.3M2026-08-24 · Fernandes Natasha sold $1.1M2025-12-15 · WELTON MARK sold $982.0K2026-08-20 · PABLO CALAMERA sold $786.2K2025-11-10 · PABLO CALAMERA sold $704.7K2025-09-15 · LISTER ROBERT D sold $656.0K2026-04-15 · GELFOND RICHARD L sold $583.7K2026-04-06 · GELFOND RICHARD L sold $522.9K2026-04-02 · GELFOND RICHARD L sold $481.5K2026-08-25 · Weissman Kenneth Ian sold $436.3K2026-04-27 · GELFOND RICHARD L sold $333.8K2026-04-14 · GELFOND RICHARD L sold $256.7K2025-11-10 · Dolci Giovanni M. sold $211.9K2025-11-24 · Fernandes Natasha sold $95.9K2026-08-06 · Zlatar Jose Aleksandr sold $24.9K2026-08-25 · KENNETH WEISSMAN filed to sell $436.3K2026-08-25 · MARK WELTON filed to sell $1.6M2026-08-24 · NATASHA FERNANDES filed to sell $1.1M2026-08-20 · Richard Gelfond filed to sell $5.3M2026-08-20 · PABLO M CALAMERA filed to sell $786.2K2026-08-19 · Richard Gelfond filed to sell $11.0M2026-08-18 · Richard Gelfond filed to sell $7.6M2026-08-06 · JOSE ALEKSANDR ZLATAR filed to sell $24.9K
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $63.1M sold by insiders over 180 days, 138 funds added last quarter, $27.9M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, IMAX CORP insiders sold a net $63.1M of stock across 51 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-04.

INSIDER
FILED
SHARES
VALUE
Weissman Kenneth Ian
Deputy GC, Corp. Sec. & CCO
SELL
2026-08-25
8,000.0
$436.3K
WELTON MARK
President IMAX Global Theatres
SELL
2026-08-25
30,000.0
$1.6M
Fernandes Natasha
Chief Financial Officer & EVP
SELL
2026-08-24
20,000.0
$1.1M
GELFOND RICHARD L
Chief Executive Officer
SELL
2026-08-20
100,000.0
$5.3M
PABLO CALAMERA
CTO & EVP
SELL
2026-08-20
15,000.0
$786.2K
51 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 46 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Orbis Allan Gray Ltd
5,149,555.0 sh
$205.3M
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
2,936,661.0 sh
$117.1M
BlackRock, Inc.
2,907,192.0 sh
$115.9M
WESTFIELD CAPITAL MANAGEMENT CO LP
2,654,014.0 sh
$105.8M
CONGRESS ASSET MANAGEMENT CO
2,537,290.0 sh
$101.1M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
KENNETH WEISSMAN
FILED 2026-08-25
$436.3K
MARK WELTON
FILED 2026-08-25
$1.6M
NATASHA FERNANDES
FILED 2026-08-24
$1.1M
Richard Gelfond
FILED 2026-08-20
$5.3M
PABLO M CALAMERA
FILED 2026-08-20
$786.2K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Nomura Small Cap Growth Fund
$24.7M POSITION · AS OF 2026-03-31
2.5%
SFT Nomura Small Cap Growth Fund
$4.0M POSITION · AS OF 2026-03-31
2.5%
Nomura VIP Small Cap Growth Series
$4.6M POSITION · AS OF 2026-03-31
2.4%
Nationwide Renaissance Small Cap Growth Fund
$573.8K POSITION · AS OF 2026-04-30
2.4%
Marsico Midcap Growth Focus Fund
$14.7M POSITION · AS OF 2026-03-31
2.2%
Keeley Small Cap Fund
$1.9M POSITION · AS OF 2026-03-31
2.2%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return · Richard L. Gelfond
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$8.7M
$21.5M
$2.3M
+105%
-34%
2024
$8.0M
$20.4M
$2.1M
+42%
-25%
2023
$8.7M
$9.4M
$2.3M
-17%
-29%
2022
$8.0M
$5.8M
$2.1M
-19%
+8%
2021
$9.1M
$9.6M
$2.6M
-1%
+32%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$410.2M$352.2M$374.8M$300.8M
GROSS PROFIT$246.2M$190.2M$214.3M$156.4M
OPERATING INCOME$84.2M$43.9M$50.4M$-4.8M
NET INCOME$34.9M$26.1M$25.3M$-22.8M
EPS (DILUTED)0.630.480.46-0.40
OPERATING CASH FLOW$127.1M$70.8M$58.6M$17.3M
CASH$151.2M$100.6M$76.2M$97.4M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-04 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-04 ALL SYSTEMS LIVE FOR MACHINES →